참고문헌
- Eom GH and Kook H (2014) Posttranslational modifications of histone deacetylases: implications for cardiovascular diseases. Pharmacol Ther 143, 168-180 https://doi.org/10.1016/j.pharmthera.2014.02.012
- Frey N and Olson EN (2003) Cardiac hypertrophy: the good, the bad, and the ugly. Annu Rev Physiol 65, 45-79 https://doi.org/10.1146/annurev.physiol.65.092101.142243
- Hill JA and Olson EN (2008) Cardiac plasticity. N Engl J Med 358, 1370-1380 https://doi.org/10.1056/NEJMra072139
- Hunter DJ and Reddy KS (2013) Noncommunicable diseases. N Engl J Med 369, 1336-1343 https://doi.org/10.1056/NEJMra1109345
- Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R and Zeiher AM (1999) Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 399, 601-605 https://doi.org/10.1038/21224
- Beg AA, Finco TS, Nantermet PV and Baldwin AS Jr (1993) Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of I kappa B alpha: a mechanism for NF-kappa B activation. Mol Cell Biol 13, 3301-3310 https://doi.org/10.1128/MCB.13.6.3301
- Maudsley S, Pierce KL, Zamah AM et al (2000) The beta(2)-adrenergic receptor mediates extracellular signalregulated kinase activation via assembly of a multi-receptor complex with the epidermal growth factor receptor. J Biol Chem 275, 9572-9580 https://doi.org/10.1074/jbc.275.13.9572
- Zhang CL, McKinsey TA, Chang S, Antos CL, Hill JA and Olson EN (2002) Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy. Cell 110, 479-488 https://doi.org/10.1016/S0092-8674(02)00861-9
- Park CW and Ryu KY (2014) Cellular ubiquitin pool dynamics and homeostasis. BMB Rep 47, 475-482 https://doi.org/10.5483/BMBRep.2014.47.9.128
- Santos-Rosa H, Valls E, Kouzarides T and Martinez-Balbas M (2003) Mechanisms of P/CAF auto-acetylation. Nucleic Acids Res 31, 4285-4292 https://doi.org/10.1093/nar/gkg655
- Gu W and Roeder RG (1997) Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90, 595-606 https://doi.org/10.1016/S0092-8674(00)80521-8
- Evans PM, Zhang W, Chen X, Yang J, Bhakat KK and Liu C (2007) Kruppel-like factor 4 is acetylated by p300 and regulates gene transcription via modulation of histone acetylation. J Biol Chem 282, 33994-34002 https://doi.org/10.1074/jbc.M701847200
- Driessen HP, de Jong WW, Tesser GI and Bloemendal H (1985) The mechanism of N-terminal acetylation of proteins. CRC Crit Rev Biochem 18, 281-325 https://doi.org/10.3109/10409238509086784
- Laherty CD, Yang WM, Sun JM, Davie JR, Seto E and Eisenman RN (1997) Histone deacetylases associated with the mSin3 corepressor mediate mad transcriptional repression. Cell 89, 349-356 https://doi.org/10.1016/S0092-8674(00)80215-9
- Nagy L, Kao HY, Chakravarti D et al (1997) Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase. Cell 89, 373-380 https://doi.org/10.1016/S0092-8674(00)80218-4
- Fischle W, Dequiedt F, Hendzel MJ et al (2002) Enzymatic activity associated with class II HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT/N-CoR. Mol Cell 9, 45-57 https://doi.org/10.1016/S1097-2765(01)00429-4
- Jones P, Altamura S, De Francesco R et al (2008) Probing the elusive catalytic activity of vertebrate class IIa histone deacetylases. Bioorg Med Chem Lett 18, 1814-1819 https://doi.org/10.1016/j.bmcl.2008.02.025
- McKinsey TA, Zhang CL and Olson EN (2000) Activation of the myocyte enhancer factor-2 transcription factor by calcium/calmodulin-dependent protein kinase-stimulated binding of 14-3-3 to histone deacetylase 5. Proc Natl Acad Sci U S A 97, 14400-14405 https://doi.org/10.1073/pnas.260501497
- Eom GH, Nam YS, Oh JG et al (2014) Regulation of acetylation of histone deacetylase 2 by p300/CBP-associated factor/histone deacetylase 5 in the development of cardiac hypertrophy. Circ Res 114, 1133-1143 https://doi.org/10.1161/CIRCRESAHA.114.303429
- Nebbioso A, Manzo F, Miceli M et al (2009) Selective class II HDAC inhibitors impair myogenesis by modulating the stability and activity of HDAC-MEF2 complexes. EMBO Rep 10, 776-782 https://doi.org/10.1038/embor.2009.88
- Chang S, McKinsey TA, Zhang CL, Richardson JA, Hill JA and Olson EN (2004) Histone deacetylases 5 and 9 govern responsiveness of the heart to a subset of stress signals and play redundant roles in heart development. Mol Cell Biol 24, 8467-8476 https://doi.org/10.1128/MCB.24.19.8467-8476.2004
- Vega RB, Harrison BC, Meadows E et al (2004) Protein kinases C and D mediate agonist-dependent cardiac hypertrophy through nuclear export of histone deacetylase 5. Mol Cell Biol 24, 8374-8385 https://doi.org/10.1128/MCB.24.19.8374-8385.2004
- Hubbert C, Guardiola A, Shao R et al (2002) HDAC6 is a microtubule-associated deacetylase. Nature 417, 455-458 https://doi.org/10.1038/417455a
- Montgomery RL, Davis CA, Potthoff MJ et al (2007) Histone deacetylases 1 and 2 redundantly regulate cardiac morphogenesis, growth, and contractility. Genes Dev 21, 1790-1802 https://doi.org/10.1101/gad.1563807
- Azechi T, Kanehira D, Kobayashi T et al (2013) Trichostatin A, an HDAC class I/II inhibitor, promotes pi-induced vascular calcification via up-regulation of the expression of alkaline phosphatase. J Atheroscler Thromb 20, 538-547 https://doi.org/10.5551/jat.15826
- Johnstone RW (2002) Histone-deacetylase inhibitors: novel drugs for the treatment of cancer. Nat Rev Drug Discov 1, 287-299 https://doi.org/10.1038/nrd772
- Kee HJ, Kwon JS, Shin S, Ahn Y, Jeong MH and Kook H (2011) Trichostatin A prevents neointimal hyperplasia via activation of Kruppel like factor 4. Vascul Pharmacol 55, 127-134 https://doi.org/10.1016/j.vph.2011.07.001
- Cincarova L, Zdrahal Z and Fajkus J (2013) New perspectives of valproic acid in clinical practice. Expert Opin Investig Drugs 22, 1535-1547 https://doi.org/10.1517/13543784.2013.853037
- Liu F, Levin MD, Petrenko NB et al (2008) Histone-deacetylase inhibition reverses atrial arrhythmia inducibility and fibrosis in cardiac hypertrophy independent of angiotensin. J Mol Cell Cardiol 45, 715-723 https://doi.org/10.1016/j.yjmcc.2008.08.015
- Zhao TC, Cheng G, Zhang LX, Tseng YT and Padbury JF (2007) Inhibition of histone deacetylases triggers pharmacologic preconditioning effects against myocardial ischemic injury. Cardiovasc Res 76, 473-481 https://doi.org/10.1016/j.cardiores.2007.08.010
- Lee TM, Lin MS and Chang NC (2007) Inhibition of histone deacetylase on ventricular remodeling in infarcted rats. Am J Physiol Heart Circ Physiol 293, H968-977 https://doi.org/10.1152/ajpheart.00891.2006
- Granger A, Abdullah I, Huebner F et al (2008) Histone deacetylase inhibition reduces myocardial ischemia-reperfusion injury in mice. FASEB J 22, 3549-3560 https://doi.org/10.1096/fj.08-108548
- Lee HA, Lee DY, Cho HM, Kim SY, Iwasaki Y and Kim IK (2013) Histone deacetylase inhibition attenuates transcriptional activity of mineralocorticoid receptor through its acetylation and prevents development of hypertension. Circ Res 112, 1004-1012 https://doi.org/10.1161/CIRCRESAHA.113.301071
- Cho YK, Eom GH, Kee HJ et al (2010) Sodium valproate, a histone deacetylase inhibitor, but not captopril, prevents right ventricular hypertrophy in rats. Circ J 74, 760-770 https://doi.org/10.1253/circj.CJ-09-0580
- Eom GH, Cho YK, Ko JH et al (2011) Casein kinase-2alpha1 induces hypertrophic response by phosphorylation of histone deacetylase 2 S394 and its activation in the heart. Circulation 123, 2392-2403 https://doi.org/10.1161/CIRCULATIONAHA.110.003665
- Kee HJ, Sohn IS, Nam KI et al (2006) Inhibition of histone deacetylation blocks cardiac hypertrophy induced by angiotensin II infusion and aortic banding. Circulation 113, 51-59 https://doi.org/10.1161/CIRCULATIONAHA.105.559724
- Kook H, Lepore JJ, Gitler AD et al (2003) Cardiac hypertrophy and histone deacetylase-dependent transcriptional repression mediated by the atypical homeodomain protein Hop. J Clin Invest 112, 863-871 https://doi.org/10.1172/JCI19137
- Kong Y, Tannous P, Lu G et al (2006) Suppression of class I and II histone deacetylases blunts pressure-overload cardiac hypertrophy. Circulation 113, 2579-2588 https://doi.org/10.1161/CIRCULATIONAHA.106.625467
- Kee HJ, Eom GH, Joung H et al (2008) Activation of histone deacetylase 2 by inducible heat shock protein 70 in cardiac hypertrophy. Circ Res 103, 1259-1269 https://doi.org/10.1161/01.RES.0000338570.27156.84
- Gallo P, Latronico MV, Gallo P et al (2008) Inhibition of class I histone deacetylase with an apicidin derivative prevents cardiac hypertrophy and failure. Cardiovasc Res 80, 416-424 https://doi.org/10.1093/cvr/cvn215
- Trivedi CM, Luo Y, Yin Z et al (2007) Hdac2 regulates the cardiac hypertrophic response by modulating Gsk3 beta activity. Nat Med 13, 324-331 https://doi.org/10.1038/nm1552
- Monteforte N, Napolitano C and Priori SG (2012) Genetics and arrhythmias: diagnostic and prognostic applications. Rev Esp Cardiol (Engl Ed) 65, 278-286 https://doi.org/10.1016/j.recesp.2011.10.008
- Ismat FA, Zhang M, Kook H et al (2005) Homeobox protein Hop functions in the adult cardiac conduction system. Circ Res 96, 898-903 https://doi.org/10.1161/01.RES.0000163108.47258.f3
- Trivedi CM, Zhu W, Wang Q et al (2010) Hopx and Hdac2 interact to modulate Gata4 acetylation and embryonic cardiac myocyte proliferation. Dev Cell 19, 450-459 https://doi.org/10.1016/j.devcel.2010.08.012
- Zhu W, Trivedi CM, Zhou D, Yuan L, Lu MM and Epstein JA (2009) Inpp5f is a polyphosphoinositide phosphatase that regulates cardiac hypertrophic responsiveness. Circ Res 105, 1240-1247 https://doi.org/10.1161/CIRCRESAHA.109.208785
- Kee HJ and Kook H (2009) Kruppel-like factor 4 mediates histone deacetylase inhibitor-induced prevention of cardiac hypertrophy. J Mol Cell Cardiol 47, 770-780 https://doi.org/10.1016/j.yjmcc.2009.08.022
- Liao X, Haldar SM, Lu Y et al (2010) Kruppel-like factor 4 regulates pressure-induced cardiac hypertrophy. J Mol Cell Cardiol 49, 334-338 https://doi.org/10.1016/j.yjmcc.2010.04.008
- Levy L, Wei Y, Labalette C et al (2004) Acetylation of beta-catenin by p300 regulates beta-catenin-Tcf4 interaction. Mol Cell Biol 24, 3404-3414 https://doi.org/10.1128/MCB.24.8.3404-3414.2004
- Chen LF, Mu Y and Greene WC (2002) Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-kappaB. EMBO J 21, 6539-6548 https://doi.org/10.1093/emboj/cdf660
- Ito A, Kawaguchi Y, Lai CH et al (2002) MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation. EMBO J 21, 6236-6245 https://doi.org/10.1093/emboj/cdf616
- Ito K, Yamamura S, Essilfie-Quaye S et al (2006) Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-kappaB suppression. J Exp Med 203, 7-13 https://doi.org/10.1084/jem.20050466
- Watamoto K, Towatari M, Ozawa Y et al (2003) Altered interaction of HDAC5 with GATA-1 during MEL cell differentiation. Oncogene 22, 9176-9184 https://doi.org/10.1038/sj.onc.1206902
- Choudhary C, Kumar C, Gnad F et al (2009) Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 325, 834-840 https://doi.org/10.1126/science.1175371
- Nott A, Watson PM, Robinson JD, Crepaldi L and Riccio A (2008) S-Nitrosylation of histone deacetylase 2 induces chromatin remodelling in neurons. Nature 455, 411-415 https://doi.org/10.1038/nature07238
- Colussi C, Mozzetta C, Gurtner A et al (2008) HDAC2 blockade by nitric oxide and histone deacetylase inhibitors reveals a common target in Duchenne muscular dystrophy treatment. Proc Natl Acad Sci U S A 105, 19183-19187 https://doi.org/10.1073/pnas.0805514105
- Malhotra D, Thimmulappa RK, Mercado N et al (2011) Denitrosylation of HDAC2 by targeting Nrf2 restores glucocorticosteroid sensitivity in macrophages from COPD patients. J Clin Invest 121, 4289-4302 https://doi.org/10.1172/JCI45144
- Brandl A, Wagner T, Uhlig KM et al (2012) Dynamically regulated sumoylation of HDAC2 controls p53 deacetylation and restricts apoptosis following genotoxic stress. J Mol Cell Biol 4, 284-293 https://doi.org/10.1093/jmcb/mjs013
- Galasinski SC, Resing KA, Goodrich JA and Ahn NG (2002) Phosphatase inhibition leads to histone deacetylases 1 and 2 phosphorylation and disruption of corepressor interactions. J Biol Chem 277, 19618-19626 https://doi.org/10.1074/jbc.M201174200
- Adenuga D and Rahman I (2010) Protein kinase CK2-mediated phosphorylation of HDAC2 regulates co-repressor formation, deacetylase activity and acetylation of HDAC2 by cigarette smoke and aldehydes. Arch Biochem Biophys 498, 62-73 https://doi.org/10.1016/j.abb.2010.04.002
- Adenuga D, Yao H, March TH, Seagrave J and Rahman I (2009) Histone deacetylase 2 is phosphorylated, ubiquitinated, and degraded by cigarette smoke. Am J Respir Cell Mol Biol 40, 464-473 https://doi.org/10.1165/rcmb.2008-0255OC
피인용 문헌
- Evidence of epigenetic tags in cardiac fibrosis vol.69, pp.2, 2017, https://doi.org/10.1016/j.jjcc.2016.10.004
- Mechanisms of transcription factor acetylation and consequences in hearts vol.1862, pp.12, 2016, https://doi.org/10.1016/j.bbadis.2016.08.011
- Proteasome inhibitors attenuated cholesterol-induced cardiac hypertrophy in H9c2 cells vol.49, pp.5, 2016, https://doi.org/10.5483/BMBRep.2016.49.5.187
- PP2A negatively regulates the hypertrophic response by dephosphorylating HDAC2 S394 in the heart vol.50, pp.7, 2018, https://doi.org/10.1038/s12276-018-0121-2
- Statins and Histone Deacetylase Inhibitors Affect Lamin A/C – Histone Deacetylase 2 Interaction in Human Cells vol.7, pp.2296-634X, 2019, https://doi.org/10.3389/fcell.2019.00006